Beyond Meat (BYND) vs Niagen Bioscience (NAGE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Niagen Bioscience (NAGE) has outperformed Beyond Meat (BYND) over the past year, losing 64.2% versus a loss of 87.6%. Over five years, NAGE leads with a -58.2% price change compared with -99.8% for BYND. Niagen Bioscience is the larger company by market cap ($210.5 million vs $132.9 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BYND | NAGE |
|---|---|---|
| Share price | $7.73 | $2.66 |
| Market cap | $132.91M | $210.48M |
| 1-day change | +0.91% | -2.21% |
| YTD return | -68.58% | -58.18% |
| 1-year return | -87.61% | -64.20% |
| 5-year return | -99.76% | -58.18% |
| P/E ratio (TTM) | — | 14.00 |
| Forward P/E | — | 26.60 |
| EPS (TTM) | $-23.40 | $0.19 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $230.70 | $7.95 |
| 52-week low | $7.50 | $2.61 |
| Distance from 52-week high | -96.65% | -66.54% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +61.71% | +354.14% |
| Average volume | 1.38M | 585.61K |
| Shares outstanding | 17.19M | 79.13M |
| Employees | 589 | 117 |
| Sector | Consumer Staples | Health Care |
| Industry | Packaged Foods | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NAGE has outperformed BYND by 23.4 percentage points over the past year.
- The two companies sit in different sectors: Beyond Meat in Consumer Staples and Niagen Bioscience in Health Care.
About Beyond Meat
BYND stock →Beyond Meat, Inc., a plant-based meat company, engages in the development, manufacture, marketing, and sale of plant-based meat products under the Beyond brand name in the United States and internationally. The company sells a range of plant-based meat products that replicates beef, pork, and poultry meats.
Consumer Staples · Packaged Foods · 589 employees
About Niagen Bioscience
NAGE stock →Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products.
Health Care · Medicinal Chemicals and Botanical Products · 117 employees
BYND vs NAGE FAQ
Which is bigger, Beyond Meat or Niagen Bioscience?
Niagen Bioscience (NAGE) is larger, with a market capitalization of $210.48M compared with $132.91M for Beyond Meat (BYND).
Which stock has performed better over the past year, BYND or NAGE?
NAGE returned -64.20% over the past 12 months, compared with -87.61% for BYND (price return, excluding dividends). Past performance does not predict future results.
Are Beyond Meat and Niagen Bioscience in the same industry?
No. Beyond Meat is in the Consumer Staples sector, while Niagen Bioscience is in Health Care.